Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02684045 · ClinicalTrials.gov registry record
Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine
A clinical trial, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- 76
- Enrollment target
NCT02684045 is a clinical trial that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 76 participants.
The verdict
NCT02684045 has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The purpose of this chart review is to assess outcomes in subjects that received MAGNIFUSE in the posterolateral lumbar spine at 1 or 2 continuous levels from L1-S1.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2017-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02684045
The ClinicalTrials.gov registry entry for NCT02684045 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02684045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02684045 about?
NCT02684045 is a clinical study titled "Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine". The purpose of this chart review is to assess outcomes in subjects that received MAGNIFUSE in the posterolateral lumbar spine at 1 or 2 continuous levels from L1-S1.
What is the current status of trial NCT02684045?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2017-03-01. Estimated completion is 2017-08-15.
Who is sponsoring clinical trial NCT02684045?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.